GlassScriptPhysician profile
Janson Jacob
NPI 1629638614
$1,499.64
in general payments reported to CMS, 2019-2025
17 companies · $621 in 2025
The $621 reported for 2025 was less than what a typical Gastroenterology (Internal Medicine) provider received nationally (typical 2025 total: $636).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $240 · 2023: $404 · 2024: $234 · 2025: $621.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,260.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,259.78 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Takeda Pharmaceuticals U.S.A., INC. | $292.66 | 2023-2025 | Entyvio, Gattex, Eohilia |
| Madrigal Pharmaceuticals | $142.36 | 2025 | Rezdiffra |
| Abbvie INC. | $128.23 | 2024-2025 | |
| Boston Scientific Corporation | $125.93 | 2023 | |
| Janssen Scientific Affairs, LLC | $125.22 | 2022 | |
| Gilead Sciences, INC. | $114.64 | 2022 | |
| Janssen Biotech, INC. | $114.59 | 2025 | Tremfya |
| Nestle Healthcare Nutrition INC. | $105.32 | 2023 | |
| Medtronic, INC. | $72.97 | 2023-2024 | Interstim, Pillcam |
| Novo Nordisk INC | $71.14 | 2025 | Wegovy |
| Qol Medical, LLC | $61.29 | 2025 | Sucraid |
| Genzyme Corporation | $44.24 | 2025 | |
| Alnylam Pharmaceuticals INC. | $25.01 | 2025 | Givlaari |
| Ipsen Biopharmaceuticals, INC | $21.98 | 2025 | Iqirvo |
| Pfizer INC. | $19.34 | 2025 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ardelyx, INC. | $17.45 | 2025 | Ibsrela |
| Aimmune Therapeutics, INC. | $17.27 | 2025 | Zenpep |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Janson Jacob listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.